Flank-Free Modified Supine Percutaneous Nephrolithotomy: Our Initial Experience from a Tertiary Care Hospital of North India and the Literature

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective The main aim of this study was to prospectively analyze and evaluate the safety and efficacy of Flank-Free Modified Supine Percutaneous Nephrolithotripsy (PCNL). Materials and Methods This hospital-based observational study was conducted in the Postgraduate Department of Surgery, Government Medical College, Srinagar. A total of 50 functional renal units were enrolled between 2016 and 2018. Baseline characteristics, puncture position, number of punctures, operation time, stone-free rate, blood loss, hospital stay, and need for secondary intervention were thoroughly studied and monitored. Results Patients ranged from 21–65 years with a mean age of 35.9 ± 9.85 years. The mean stone size was 17.3 ± 1.81 mm (range: 14.2–21 mm). Most patients (40%) had stones measuring 16-17.9 mm. Pelvic stones were found in 28 patients (56%), followed by lower calyx stones in 14 patients (28%), and 8 patients (16%) had stones in both pelvis and lower calyx. The mean operative time was 83.62 ± 16.95 minutes (range: 60–115 minutes). Mean nephrostomy duration was 2.1 days (range: 2–3 days). Three patients (6%) required extracorporeal shock wave lithotripsy (ESWL) as auxiliary treatment. Mean hospital stay was 3.7 ± 1.15 days, with 52% of patients staying 2–3 days. The major complication was need for auxiliary treatment in 3 patients (6%), followed by conversion to prone position and postoperative fever in 2 patients (4%) each. Conclusions Flank-Free Modified Supine PCNL is both effective and safe, offering favorable outcomes regarding patient compliance, urologist ease, and associated complications/morbidity.

Article activity feed